VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Post Hugh 👏Good news coming Mayo Clinic! 🤔👀

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Aug 20, 2024 11:41am

58 Views

Post# 36187993

RE:RE:Post Hugh 👏Good news coming Mayo Clinic! 🤔👀

jopatclo wrote: Good comment

1
from #vpt, 17 Aug 2024, 09:13

@cardinal 4.o, Mayo, reference site partnerships, branding,

7
from #vpt, 17 Aug 2024, 12:31

@hassy Interesting to see Hugh's post today. "Working in the US midwest with Strategic Sales Manager Scott Hammerling this past week provided an excellent opportunity to meet with cardiologists and sonographers to discuss how VMS+ can integrate within their clinical workflows. We received positive feedback on the accuracy of RV measurements and the potential to achieve better patient compliance with scheduled studies." Why is this interesting? Mayo's HO happens to be in MN (US Midwest, being a Canadian, I had to look it up to make sure! lol) https://www.linkedin.com/posts/hugh-macnaught-961255_working-in-the-us-midwest-with-strategic-activity-7230719558850859009-GYlL?utm_source=share&utm_medium=member_desktop

9
from #vpt, about 11 hours ago

@cardinal That will be their biggest of the big. What building is that

8
from #vpt, about 10 hours ago

@cardinal Ventripoint is finally there….

8
from #vpt, about 10 hours ago

jopatclo wrote:

Posts de Hugh

Post du fil d’actualit

Hugh MacNaught • 3e et +President and CEO at Ventripoint Diagnostics Ltd.Il y a 12 heures

Working in the US midwest with Strategic Sales Manager Scott Hammerling this past week provided an excellent opportunity to meet with cardiologists and sonographers to discuss how VMS+ can integrate within their clinical workflows. We received positive feedback on the accuracy of RV measurements and the potential to achieve better patient compliance with scheduled studies.

Wow comment positive de
@Investor765 Well we now know for certain that they were at Mayo clinic. This is positive, even tough it might have been a sale visit ! There is no evidence that any deal is imminent... healthcare takes forever... At least, Hugh is engaging directly Mayo and does not rely on mediocre distributors. I feel more confident knowing he is in the field pitching VPT
and good comment

@cardinal Mayo has over 100 sonographers. They have endless ultrasound and MRI. They need VMS it’s that simple. Ventripoint AI solution and right Ventricle precision is game changing. When Mayo buys, they all buy. GL

about 3 hours ago

@cardinal six or seven weeks ago was best week ever. Last week was that again.

about 3 hours ago

@cardinal Insiders and family paid .25 in the raise. Look for follow up. Under .25 is a gift

<< Previous

Bullboard Posts

Next >>

FLYHT and WestJet partner on weather forecasting